RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Practical Aspects of Conducting Clinical Trials in India

Practical Aspects of Conducting Clinical Trials in India

Posted 01 February 2009 | By Mukesh Kumar

India is an attractive destination for conducting clinical trials. A young, highly educated work-force, a very large population concentrated in a few urban centers, prevalence of all major diseases, and importantly, use of English as the primary language make it easy to set up clinical sites in India.1,2 Over the last couple of years, Indian regulatory and business processes have gone through several enhancements to harmonize with the rest of the world with the goal of making it easier for India to participate in global trials.3 Outsourcing a clinical trial to India offers the promise of rapid completion and reduced cost to a sponsor from the US, Canada and Europe. It is widely projected that India might become a major destination for outsourced clinical trials in the next few years.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.